The CARA System, which received FDA Breakthrough Device Designation last year, enables visualization of the location of the cardiac conduction system relative to surrounding cardiac structures during structural heart and pacing procedures.

The system is intended for the preplanning and guidance of medical interventions in areas known to contain or be adjacent to the cardiac conduction system. These include percutaneous or surgical procedures such as transcatheter aortic valve replacement (TAVR), as well as procedures in which physicians seek to deliver therapy to the patient’s cardiac conduction system or to a targeted location within it, including conduction system pacing (CSP).